Epox

Epox develops advanced polymers using C1 molecules, particularly CO₂, as molecular building blocks. By incorporating CO₂ into materials engineered for industrial applications, from packaging to high-performance uses, we transform an environmentally challenging carbon source into a valuable resource for technological innovation.

Epox holds patents protecting both the synthesis processes and the resulting materials for biodegradable polymers belonging to the polypropylene carbonate (PPC) family.

Epox develops functional polymers whose performance is engineered through precise control of molecular architecture and reticulation. We design polymer networks to achieve tailored physical, chemical and biological properties, including controlled degradation, mechanical performance and responsiveness.

Applications range from biodegradable scaffolds for regenerative medicine, where degradation can be synchronized with tissue regeneration, to hydrogels designed for the controlled release of bioactive compounds, enabling increasingly sophisticated technological and biomedical applications.

In DNA, RNA and proteins, the precise order of molecular building blocks gives these polymers a further dimension: information. Sequence can be seen as a “language” through which biological systems encode instructions, regulate processes and shape cellular responses.

Epox operates in this field through Solid Script, its dedicated branch focused on the design and optimization of biological sequences. Combining molecular biology, experimental validation and AI-assisted tools, Solid Script investigates how sequence design can modulate targeted biological responses and create new opportunities in biotechnology.